Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark

A Diet Rich In Fatty Fish Is Beneficial In Reducing Progress Of Eye Disease
A study published ahead of print in the British Journal of Ophthalmology suggests that in order to diminish the development of the age related eye disease called macular degeneration, a weekly consumption of two to three portions of fatty fish could be beneficial.
generic viagra online
The Dangers Of 'Extreme' College Drinking And A Sensation-Seeking Disposition
Drinking on college campuses in the United States is a pervasive problem, leading to numerous problems. One study estimated that more than 500,000 college students suffered alcohol-related injuries in 2001. This study examined the "dose-response" effect of quantities and frequencies, finding that heavy drinkers with a sensation-seeking disposition had the greatest risk of alcohol-related injuries.
News of the day
CHMP Recommends 'Januvia(R)'(sitagliptin), From MSD, For Restricted First Line Use In European Union
Merck & Co., Inc. (Whitehouse Station, N.J., U.S.A.), which operates in many countries as Merck Sharp & Dohme (MSD), has received a positive opinion from the European Medicines Agency"s (EMEA) Committee for Medicinal Products for Human Use (CHMP) recommending restricted first line use of "Januvia" (sitagliptin) for the treatment of type 2 diabetes. With this positive opinion, the CHMP recommends that sitagliptin be indicated to improve glycaemic control when diet and exercise alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. If this opinion is accepted by the European Commission, sitagliptin will be the only diabetes treatment in the DPP-4 inhibitor class to have a restricted first line indication.
Medical Devices

Radiotherapy Services In England: Good Progress But Still Work To Do

A survey by The Royal College of Radiologists (RCR) has confirmed that there are marked geographical variations in patients" access to radiotherapy, and also important differences in treatment capacity, across England. The survey is presented by Dr Michael Williams, in a paper appearing in the July 2009 edition of the journal Clinical Oncology. Radiotherapy is a key component of high quality modern cancer care, playing a vital role in curative and also in palliative treatments. This survey highlights the crucial relationship between available treatment capacity and patterns of practice with reduced access, and numbers of treatments per patient (fractionation) where that capacity is inadequate. Dr Jane Barrett, Dean of the RCR"s Faculty of Oncology, said, "It has been known for some time that socially deprived patients have worse outcomes for a range of cancers. This research shows that access to radiotherapy varies across the UK and is affected by deprivation. It is likely that deprived patients present later with more advanced tumours which are more difficult to treat. Further research will be necessary to establish ways of improving treatment and outcomes for such patients. "English Strategic Health Authorities and health authorities in the devolved UK countries should consider the findings of this survey in their ongoing reviews of radiotherapy services, and we will continue to work with health services throughout the UK to ensure that new res for workforce and treatment capacity are targeted on areas where there is inadequate access/service." Notes 1. The paper, Geographical variation in radiotherapy services across the UK in 2007 and the impact of deprivation, appears in the July 2009 edition of the Royal College of Radiologists" journal Clinical Oncology; a copy of the paper can be provided on request. Clinical Oncology is the scientific journal of the Royal College of Radiologist"s Faculty of Clinical Oncology, published ten times a year; more information is available at http://www.rcr.ac.uk/content.aspx?PageID=153. 2. The Royal College of Radiologists (RCR) has approximately 7800 members and Fellows worldwide, representing the disciplines of clinical oncology and clinical radiology. All members and Fellows of the College are registered medical or dental practitioners. 3. The Cancer Reform Strategy was published in 2007, the same year as this survey, with improvement of radiotherapy services as one of its key priorities, and new radiotherapy centres have since been commissioned in some key places. Radiotherapy as a treatment is undergoing very rapid technological advances, notably Intensity Modulated and Image Guided Radiotherapy (IMRT and IGRT), that enable higher cure rates with fewer side effects. These higher quality treatment techniques should be delivered at the same time as the introduction of greater treatment capacity. The Royal College of Radiologists


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009